Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.00
Bid: 140.00
Ask: 160.00
Change: 5.00 (3.45%)
Spread: 20.00 (14.286%)
Open: 150.00
High: 150.00
Low: 150.00
Prev. Close: 145.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Churchill China Sales Hit By Virus

Thu, 11th Jun 2020 13:23

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Thursday and not separately reported by Alliance News:

----------

Churchill China PLC - Stoke-on-Trent-based ceramic products maker - Virus impacts sales to hospitality markets significantly. Following a strong start to 2020, trading in April and May well below normal levels. Several actions taken to mitigate the effect of reduction in activity. Seeing first signs of an improvement in trading with growing levels of orders and activity. Anticipates increased market demand over the next few months. Overall monthly revenue to remain below 2019 levels for some time as hospitality market activity re-adjusts. Consulting with employees in relation to the potential reduction in the size of workforce. No decision yet been made on the number of redundancies.

----------

Princess Private Equity Holding Ltd - Guernsey-based investment company - Completes stake sale in non-food discount retailer Action. Received initial proceeds of EUR80.9 million following the closing. Transaction involves deferred proceeds of EUR9.1 million. Stake sale has no impact on net asset value. Cash position following the stake sale stands at EUR107.0 million.

----------

Secure Property Development & Investment PLC - County Durham, England-based eastern Europe focused property investor - Gets three month extension to publish 2019 results. Confident that 2020 results will not suffer any material adverse effects from the coronavirus pandemic crisis. 2019 results to be in line with management expectations with 18% year-on-year rise in rental income to EUR2.1 million.

----------

Agronomics Lted - Isle of Man-based biotechnology investor - Invests EUR1 million in Dutch cultivated meat company Meatable BV. Buys 997 preferred shares in Meatable's Seed 2 financing. Will ultimately own a 6.5% stake in Meatable following conversion of a EUR2 million loan note.

----------

REA Holdings PLC - London-based palm oil producer focused on Indonesia - Production in the first few months of 2020 at good levels. With many harvesters unable to travel home for the traditional Ramadan holiday, productivity has been maintained. Crude palm oil production for the year to May 31 increased 5.1% year-on-year to 83,400 tonnes. Crude palm kernel oil production up 20% at 5,400 tonnes. Fresh fruit bunch harvest increases 4.8% to 370,000 tonnes. Crude palm oil prices fell to USD510 per tonne in mid-May from USD860 on January 1. Since then, prices have recovered moderately to current level USD595 per tonne. Taking steps to reduce costs including cutting 200 staff, mostly temporary workforce.

----------

ADES International Holding PLC - UAE-based oil & gas drilling services provider - Sees 22% year-on-year jump in revenue for the three months to March 31. April saw continuation of first-quarter revenue trends. Utilisation rate 96% versus 92%. Margins broadly in line with 2019. Order backlog at USD1.34 billion at end of first-quarter versus USD1.31 billion at 2019-end. Net debt of USD640.3 million as at March 31. Continues to expect a similar earnings before interest, tax, depreciation and amortisation performance for 2020 to that achieved in 2019. Anticipates modest reduction in utilisation rates in 2020 due to the oil price volatility.

----------

Anglo African Oil & Gas PLC - London-based cash shell - Secures GBP1.5 million unsecured convertible loan from Riverfort Global Opportunities PCC Ltd. Each drawdown is interest free but attracts a 7% drawdown fee to be added to the principal amount outstanding and convertible on the same terms. All drawdowns and fees associated with them will be convertible into ordinary shares.

----------

Ironveld PLC - Cardiff, Wales-based iron miner focused on South Africa - Applies for ZAR240 million, around GBP11.3 million, project development funding to a major South African lender for commencing mining and production at magnetite project. Partner Inclusive Investment Group Proprietary Ltd agrees to provide a bridge funding facility of up to ZAR3.70 million. Extends option pact for Inclusive Investment to buy 440.2 million Ironveld shares at 0.42 pence per share. The option was to expire on Wednesday next week.

----------

Faron Pharmaceuticals Oy - Finland-based drug discovery company - Selected to receive a EUR2.5 million grant from the European Innovation Council Accelerator pilot scheme to progress the Matins study and related business activities. Matins clinical trial is investigating the tolerability, safety and efficacy of Clevegen, Faron's novel precision cancer immunotherapy targeting Clever-1 positive tumour associated macrophages in selected metastatic or inoperable solid tumours.

----------

Cohort PLC - Reading, England-based defence technology provider - Subsidiary Chess Dynamics awarded a EUR7.5 million contract for its Air Guard Counter-Unmanned Aerial Systems for air base and critical infrastructure protection for an international customer. Majority of the contract to be delivered during the current and next financial years. Contract further underpins group revenue and short and medium term outlook.

----------

Amur Minerals Corp - Khabarovsk, Russia-based minerals explorer - Receives non-binding indicative offtake terms for both the nickel and copper concentrates from Kun-Manie project in Russia. Gipronickel Institute conducting metallurgical testwork programme on Kun-Manie.

----------

Europa Oil & Gas Holdings PLC - London-based oil & gas explorer - Acquiring 100% interest in Frontier Exploration Licence 3/19, offshore Ireland, from DNO for a nominal upfront fee and the granting of a 5% net profits interest over future production of gas and liquids from any accumulation on FEL 3/19 to DNO. Licence will add 1.2 trillion cubic feet of gas to Europa's inventory in Ireland.

----------

Greatland Gold PLC - London-based precious metals explorer - Reports exceptional drill results from Havieron deposit in the Paterson region of Western Australia. Results demonstrate improved continuity in the high-grade crescent sulphide zone and extend the strike length of mineralisation to 550 metres in the upper 200 metres of that zone. Drilling has also provided further confirmation of the potential for a bulk tonnage target in the adjacent breccia hosted mineralisation. Farm-in partner Newcrest Mining Ltd planning further 80,000 metres of drilling at Havieron over the next 12 months.

----------

Ariana Resources PLC - London-based gold explorer - Reports 50% rise in resource estimate for Tavsan project in Turkey to 4.49 million tonnes for 253,000 ounces of gold and 723,000 ounces of silver. Estimate further de-risked with 77% of the resource now in the measured and indicated JORC categories. Discussions with potential lenders to commence imminently to secure funding for the development of the project. Tavsan is part of the Red Rabbit Joint Venture with Proccea Construction Co and is 50% owned by Ariana.

----------

MetalNRG PLC - London-based natural resources investor - Identifies a number of onshore oil & gas assets in the UK. Enters into preliminary agreement with the owners of a small portfolio of onshore, conventional, oil & gas producing licences. Finalising the required funding for the acquisition. Working on development plans for its Gold Ridge gold mine in the US state of Arizona, which will help minimise risk and create a sustainable path to revenues from the waste resources left behind from previous operators and resource from new unexplored areas. Proposes alternative commercial terms to vendor for the potential oil & gas acquisition in Romania.

----------

Open Orphan PLC - London-based pharmaceutical services provider - Unit Venn Life Sciences signs a major contract with a leading vaccine developer and one of the top pharmaceutical companies in the world. Contract is to obtain and support market access of newly developed vaccines into the EU and US markets until the end of 2020.

----------

Inspiration Healthcare Group PLC - Crawley, West Sussex-based medical technology supplier - Gets grant award for Project Wave which is developing a novel technology for a respiratory device designed to be used in neonatal intensive care. Grant towards the cost of trials expected to commence this year on 20 babies at Trevor Mann Unit, Brighton & Sussex University Hospital. Med Tech Trials Innovation Support Grant awarded by the Academic Health Science Networks and part financed by the European Regional Development Fund, which will contribute up to 50%, or GBP50,000 maximum, towards the costs of the trials.

----------

Woodbois Ltd - London-headquartered forestry and agriculture company - To recommence limited operations in Gabon next week. Seeing gradual increase in trading enquiries. Enquiries and demand levels, particularly from Asia and the Middle East, have started to return. Zahid Abbas and Jacob Hansen have stepped down from board but will remain as head of trading and chief operating officer respectively. In talks to restructure unlisted debt instruments to strengthen financial position.

----------

STV Group PLC - Scottish broadcaster - Agrees a deal with Virgin Media which will enable its TV customers across the UK to watch the STV Player via their set top box. STV Player app and catch-up service was integrated into Virgin Media's set top boxes for viewers in Scotland in December 2018. This new deal ensures that STV content can now be accessed throughout the UK, considerably extending the reach of the STV Player.

----------

Matomy Media Group Ltd - Tel Aviv-Yafo, Israel-based cash shell - Shares to be suspended from the London Stock Exchange's main market on June 23. Shares will continue trading on the Tel Aviv Stock Exchange. Matomy continues to consider its options and scouting for new opportunities going forward.

----------

By Tapan Panchal; tapanpanchal@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
14 Oct 2022 11:14

Faron Pharmaceuticals shares down as raises EUR8.4 million in placing

(Alliance News) - Faron Pharmaceuticals Ltd shares declined on Friday, after it said it has raised EUR8.4 million from a share placing.

Read more
13 Oct 2022 21:17

TRADING UPDATES: Bidstack names new COO; Fintel expands deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Aug 2022 12:10

REPEAT: Faron Pharma half-year loss widens on higher R&D spending

(Alliance News) - Faron Pharmaceuticals Ltd on Thursday said its interim loss widened, as the company reported higher research and administrative expenses and remained revenue-less.

Read more
25 Aug 2022 11:43

Faron Pharmaceuticals half-year loss widens on higher R&D spending

(Alliance News) - Faron Pharmaceuticals Ltd on Thursday said its interim loss widen, as the company reported higher research and administrative expenses and remained revenue-less.

Read more
18 Aug 2022 16:02

UK earnings, trading statements calendar - next 7 days

Friday 19 August 
Apax Global Alpha LtdHalf Year Results
Kingspan Group PLCHalf Year Results
Newcrest Mining LtdFull Year Results
Monday 22 August 
Smoove PLCFull Year Results
Tuesday 23 August 
Aferian PLCHalf Year Results
John Wood Group PLCHalf Year Results
Wednesday 24 August 
Costain Group PLCHalf Year Results
Lookers PLCHalf Year Results
Standard Chartered PLCHalf Year Results
Thursday 25 August 
Amigo Holdings PLCQ1 Results
Anglo Pacific Group PLCHalf Year Results
Benchmark Holdings PLCQ3 Results
CRH PLCHalf Year Results
Faron Pharmaceuticals LtdHalf Year Results
Grafton Group PLCHalf Year Results
Harbour Energy PLCHalf Year Results
Hays PLCFull Year Results
Hunting PLCHalf Year Results
Macfarlane Group PLCHalf Year Results
Morses Club PLCFull Year Results
South32 LtdFull Year Results
  
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
30 Jun 2022 15:59

UK shareholder meetings calendar - next 7 days

Friday 1 July 
All Star Minerals PLCGM re name change to Marula Mining
Monday 4 July 
Active Energy Group PLCAGM
Clean Invest Africa PLCAGM
Securities Trust of Scotland PLCAGM
Tuesday 5 July 
Immediate Acquisition PLCAGM
Marks & Spencer Group PLCAGM
Open Orphan PLCAGM
Saga PLCAGM
Smartspace Software PLCAGM
Young & Co's Brewery PLCAGM
Wednesday 6 July 
Assura PLCAGM
ContourGlobal PLCGM re acquisition by KKR
GSK PLCGM re Consumer Healthcare demerger, Haleon listing
Mining Minerals & Metals PLCAGM
PCF Group PLCGM re director allotment authority
Puma Alpha VCT PLCAGM
Shires Income PLCAGM
Sirius Real Estate LtdAGM
Strategic Minerals PLCAGM
Worldwide Healthcare Trust PLCAGM
Thursday 7 July 
C&C Group PLCAGM
Distil PLCAGM
Emmerson PLCAGM
Faron Pharmaceuticals LtdGM re issuance of shares
FD Technologies PLCAGM
Great Portland Estates PLCAGM
Greencare Capital PLCAGM
J Sainsbury PLCAGM
JPMorgan European Growth & Income PLCAGM
Land Securities Group PLCAGM
Likewise Group PLCGM re approval of waiver by takeover/merger panel
N Brown Group PLCAGM
Octopus Apollo VCT PLCAGM
Peel Hunt LtdAGM
Pets At Home Group PLCAGM
Puma VCT 13 PLCAGM
Severn Trent PLCAGM
TomCo Energy PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
28 Jun 2022 18:03

IN BRIEF: Faron raises EUR5 million for bexmarilimab development

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - Conducts private placing to raise EUR5 million in 2.0 million newly issued treasury shares at EUR2.49 each. Once the funds are received, Faron expects to have sufficient working capital to last until the first quarter of 2023. Net proceeds will be largely used for the acceleration of the clinical development program and manufacturing of bexmarilimab, its immunotherapy asset.

Read more
15 Jun 2022 19:24

IN BRIEF: Faron Pharma reveals topline results from MATINS trial

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - Announces top-line overall survival results from its phase 1/2 'Macrophage Antibody To Inhibit Immune Suppression study, which investigated the safety and efficacy of bexmarilimab monotherapy in ten different hard-to-treat or on operable solid tumour cohorts.

Read more
8 Jun 2022 16:54

IN BRIEF: Faron Pharma doses first patient in bexmarilimab study

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - Doses first patient in the phase I/II BEXMAB study. The study is investigating bexmarilimab, Faron's wholly-owned precision immunotherapy asset, in combination with azacitidine in multiple hematological malignancies. This marks the first time bexmarilimab is being assessed as part of a clinical study in hematologic malignancies, Faron explains.

Read more
16 May 2022 17:35

IN BRIEF: US and Finland approve Faron's bexmarilimab study

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - US Food & Drug Administration and Finnish Medicines Agency clear company's investigational new drug application to start its BEXMAB study, which is for assessing the safety, tolerability and efficacy of precision cancer immunotherapy known as bexmarilimab.

Read more
12 May 2022 19:45

TRADING UPDATES: Belluscura to raise GBP5 million; React buys

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
8 Apr 2022 19:30

IN BRIEF: Faron Pharmaceuticals CEO buys shares worth EUR71,000

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - Chief Executive Markku Jalkanen buys 25,000 shares at an average price of EUR2.82, worth EUR70,533, on Tuesday.

Read more
5 Apr 2022 20:45

TRADING UPDATES: Rambler ups production; SRT Marine anticipates loss

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
25 Mar 2022 13:21

EARNINGS UPDATES: Everyman revenue doubles; Aeorema in interim profit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
18 Mar 2022 16:09

UK earnings, trading statements calendar - next 7 days

Monday 21 March 
Photo-Me International PLCFull Year Results
Spectral MD Holdings LtdFull Year Results
Sthree PLCTrading Statement
Tuesday 22 March 
Alliance Pharma PLCFull Year Results
BioPharma Credit PLCFull Year Results
Circassia Group PLCFull Year Results
Diaceutics PLCFull Year Results
Diurnal Group PLCFull Year Results
IQGeo Group PLCFull Year Results
Longboat Energy PLCFull Year Results
Luceco PLCFull Year Results
MaxCyte IncFull Year Results
MP Evans Group PLCFull Year Results
Oxford Nanopore Technologies PLCFull Year Results
Pebble Group PLCFull Year Results
Real Estate Investors PLCFull Year Results
Sabre Insurance Group PLCFull Year Results
ScS Group PLCHalf Year Results
Softcat PLCHalf Year Results
Staffline Group PLCFull Year Results
Trustpilot Group PLCFull Year Results
YouGov PLCHalf Year Results
Zotefoams PLCFull Year Results
Wednesday 23 March 
Dignity PLCFull Year Results
ECSC Group PLCFull Year Results
Henry Boot PLCFull Year Results
Judges Scientific PLCFull Year Results
Pendragon PLCFull Year Results
Saga PLCFull Year Results
SigmaRoc PLCFull Year Results
Thursday 24 March 
Arbuthnot Banking Group PLCFull Year Results
Atalaya Mining PLCFull Year Results
Big Technologies PLCFull Year Results
Biome Technologies PLCFull Year Results
Bonhill Group PLCFull Year Results
Bridepoint Group PLCFull Year Results
CVS Group PLCHalf Year Results
Energean PLCFull Year Results
EnQuest PLCFull Year Results
Eve Sleep PLCFull Year Results
International Public Partnerships LtdFull Year Results
Kin & Carta PLCFull Year Results
Next PLCFull Year Results
Safestyle UK PLCFull Year Results
Secure Trust Bank PLCFull Year Results
Sopheon PLCFull Year Results
Starwood European Real Estate LtdFull Year Results
WAG Payment Solutions PLCFull Year Results
Friday 25 March 
Electrocomponents PLCTrading Statement
Faron Pharmaceuticals LtdFull Year Results
Smiths Group Half Year Results
United Utilities Group PLCTrading Statement
Wickes Group PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.